PharmaCyte Biotech Inc.

Last updated September 27, 2026

Organization details

Legal name
PharmaCyte Biotech Inc.
Former names
Nuvilex, INC. Efoodsafety COM Inc
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Nevada
Headquarters city
LAS Vegas
Headquarters state / province
Nevada
Headquarters country
United States
Fiscal year end
April
Ticker symbol
PMCB
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001157075
EIN
62-1772151

Board of directors

Chief executives

Joshua Silverman · Interim CEO, Interim President Interim
Dates unknown

Director election results

Annual meeting of March 30, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

4 of this board's directors also sit on 9 other boards. 2 are in the same sector.

Network of PharmaCyte Biotech Inc.'s board connections Fabric.AI Inc. Fabric.AI Inc. Tao Synergies Inc. Tao Synergies Inc. TaoWeave Inc. TaoWeave Inc. Femasys Inc. Femasys Inc. Outdoor Holding Company Outdoor Holding Compan... Pitney Bowes Inc. Pitney Bowes Inc. Q/C Technologies Inc. Q/C Technologies Inc. Wrap Technologies Inc. Wrap Technologies Inc. XWELL Inc. XWELL Inc. Jonathan Schechter Jonathan Schechter Joshua Silverman Joshua Silverman Robert Weinstein Robert Weinstein Wayne Remell Walker Wayne Remell Walker PharmaCyte Biotech Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$128,500
6 purchases by 2 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Jan 7, 2026 Joshua Silverman Director, Officer (CEO and President) Open-market purchase +40,000 $0.83 $33,200
Jan 7, 2026 Jonathan Schechter Director Open-market purchase +20,000 $0.84 $16,800
Jan 6, 2026 Joshua Silverman Director, Officer (CEO and President) Open-market purchase +30,000 $0.79 $23,700
Jan 6, 2026 Jonathan Schechter Director Open-market purchase +20,000 $0.79 $15,800
Jan 5, 2026 Joshua Silverman Director, Officer (CEO and President) Open-market purchase +30,000 $0.78 $23,400
Jan 5, 2026 Jonathan Schechter Director Open-market purchase +20,000 $0.78 $15,600
Dec 12, 2025 Robert Weinstein Director Grant or award +75,000 — —
Dec 12, 2025 Wayne Remell Walker Director Grant or award +37,500 — —
Dec 12, 2025 Joshua Silverman Director, Officer (CEO and President) Grant or award +575,000 — —
Dec 12, 2025 Jonathan Schechter Director Grant or award +150,000 — —
Dec 12, 2025 Michael M. Abecassis Director Grant or award +37,500 — —
Dec 12, 2025 Robert Weinstein Director Shares withheld for tax −33,750 $1.02 $34,425
Dec 12, 2025 Wayne Remell Walker Director Shares withheld for tax −16,875 $1.02 $17,213
Dec 12, 2025 Joshua Silverman Director, Officer (CEO and President) Shares withheld for tax −258,750 $1.02 $263,925
Dec 12, 2025 Jonathan Schechter Director Shares withheld for tax −67,500 $1.02 $68,850

Organizations in the same sector, closest in location and size first.

Questions about PharmaCyte Biotech Inc.

Who is the CEO of PharmaCyte Biotech Inc.?

Joshua Silverman is PharmaCyte Biotech Inc.'s Interim CEO, Interim President.

How many directors are on PharmaCyte Biotech Inc.'s board?

PharmaCyte Biotech Inc.'s board has 6 directors: Carlos Trujillo, Jonathan Schechter, Joshua Silverman, Michael M. Abecassis, Robert Weinstein and Wayne Remell Walker.

Are PharmaCyte Biotech Inc. insiders buying or selling shares?

Over the last 12 months, PharmaCyte Biotech Inc. insiders bought $128,500 of shares in 6 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="pharmacyte-biotech-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.